Based on the knockdown of MBTPS1, the inhibition of the type 1 interferon pathway completely inhibits tumor proliferation, which suggests that MBTPS1 can be used as a therapeutic target for the treatment of colon cancer (52). This evidence concerns the gene MBTPS1 and neoplasm.